Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Giorgio

Denis Giorgio, Remscheid DE

Patent application numberDescriptionPublished
20100276561ADJUSTING DEVICE FOR THE LONGITUDINAL ADJUSTMENT OF AN AUTOMOTIVE COMPONENT - The invention relates to an adjusting device for the longitudinal adjustment of an automotive component, especially a vehicle seat. The adjusting device comprises an upper longitudinal rail with respect to the adjusting device and a lower longitudinal rail with respect to the adjusting device. The adjusting device comprises a locking device in such a manner that when the locking device is activated, a relative adjustment of the longitudinal rails in relation to each other can be blocked and when the locking device is released, the longitudinal rails can be unblocked. The locking device comprises a plurality of detent pins, at least one detent pin being adjusted in the locking position to lock the longitudinal rails and all detent pins being adjusted in a release position to release the longitudinal rails. The detent pins have a detent profile that is designed in such a manner that a first front section of the detent pin has a flare angle and a second section of the detent pin has a transition.11-04-2010

Marco Giorgio, San Genesio IT

Patent application numberDescriptionPublished
20100099736PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR BLOCKING DEGENERATIVE TISSUE DAMAGES BY INHIBITING MPT - The invention discloses the use of a compound of formula (I), wherein R04-22-2010

Nicholas A. Giorgio, New York, NY US

Patent application numberDescriptionPublished
20090099339ANTIBODY AND ANTIBODY FRAGMENTS FOR INHIBITING THE GROWTH OF TUMORS - Chimerized and humanized versions of anti EGF receptor antibody 225 and fragments thereof for treatment of tumors.04-16-2009

Todd Donald Giorgio, Nashville, TN US

Patent application numberDescriptionPublished
20100261212KINETICS OF MOLECULAR RECOGNITION MEDIATED NANOPARTICLE SELF-ASSEMBLY - A method of multiple protein biomarker detection, comprising providing at quantum dot-antibody conjugates that have an affinity for at least two different protein biomarkers; contacting the conjugates with a sample from a subject; allowing the proteins to bridge the antibodies, forming protein biomarker/quantum dot-antibody conjugate agglomerates; detecting the presence of the biomarkers by excitation of the agglomerates.10-14-2010